Anavex Life Sciences
AVXL
$11.65
Share price
6.01%
Change (1 day)
-40.41%
Change (1 year)
Categories
Earnings for Anavex Life Sciences (AVXL)
Earnings in 2022 (TTM): -$47.96 M
According to Anavex Life Sciences 's latest financial reports the company's current earnings (TTM) are -$47.96 M. In 2021 the company made an earning of -$44.28 M a decrease over its 2020 earnings that were of -$32.71 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Anavex Life Sciences from 2005 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | -$47.96 M | 8.31% |
| 2021 | -$44.28 M | 35.36% |
| 2020 | -$32.71 M | 12.65% |
| 2019 | -$29.04 M | 29.09% |
| 2018 | -$22.5 M | 36.33% |
| 2017 | -$16.5 M | 17.11% |
| 2016 | -$14.09 M | 20.91% |
| 2015 | -$11.66 M | -6.28% |
| 2014 | -$12.44 M | 337.24% |
| 2013 | -$2.85 M | |
| 2009 | -$4.7 M | -10.68% |
| 2008 | -$5.26 M | 111.86% |
| 2007 | -$2.49 M | 8601.97% |
| 2006 | -$0.03 M | -79.99% |
| 2005 | -$0.15 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Ligand Pharmaceuticals LGND | -$2.41 M | -94.98% | 🇺🇸 USA |
 Corcept Therapeutics
CORT | $0.13 B | -373.38% | 🇺🇸 USA |
 Palatin Technologies PTN | -$37.34 M | -22.13% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | -$0.21 B | 330.10% | 🇺🇸 USA |